ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Dramatic Increase In Third World Cancer Rates May Face National, International Organizations: Murphy

September 17, 1982

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

Harkin, Hatfield Propose Cigarette Tax To Fund NIH Research

September 22, 1995

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990